These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12691796)

  • 1. Is mannitol safe for patients with intracerebral hemorrhages? Renal considerations.
    Dziedzic T; Szczudlik A; Klimkowicz A; Rog TM; Slowik A
    Clin Neurol Neurosurg; 2003 Apr; 105(2):87-9. PubMed ID: 12691796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the use of hypertonic mannitol appropriate in the management of intracerebral hemorrhage?
    Prakash ES
    Stroke; 2008 May; 39(5):e85; author reply e86-7. PubMed ID: 18356545
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of osmotherapy in intracerebral hemorrhage.
    Kalita J; Ranjan P; Misra UK
    Neurol India; 2003 Mar; 51(1):104-9. PubMed ID: 12865537
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperosmolar therapy for raised intracranial pressure.
    Ropper AH
    N Engl J Med; 2012 Aug; 367(8):746-52. PubMed ID: 22913684
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline.
    Qureshi AI; Wilson DA; Traystman RJ
    Neurosurgery; 1999 May; 44(5):1055-63; discussion 1063-4. PubMed ID: 10232539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of early renal function before and after using mannitol in patients with cerebral apoplexy].
    Zhu X; Luo JA; Liu Z; Xiao P; Liao K; Hu Z
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):159-61. PubMed ID: 9868062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for Mannitol as an Effective Agent Against Intracranial Hypertension: An Individual Patient Data Meta-analysis.
    Poole D; Citerio G; Helbok R; Ichai C; Meyfroidt G; Oddo M; Payen JF; Stocchetti N
    Neurocrit Care; 2020 Feb; 32(1):252-261. PubMed ID: 31264071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmolality not predictive of mannitol-induced acute renal insufficiency.
    Gondim Fde A; Aiyagari V; Shackleford A; Diringer MN
    J Neurosurg; 2005 Sep; 103(3):444-7. PubMed ID: 16235675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mannitol bolus administration on intracranial pressure, cerebral extracellular metabolites, and tissue oxygenation in severely head-injured patients.
    Sakowitz OW; Stover JF; Sarrafzadeh AS; Unterberg AW; Kiening KL
    J Trauma; 2007 Feb; 62(2):292-8. PubMed ID: 17297315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenging the gold standard: should mannitol remain our first-line defense against intracranial hypertension?
    Infanti JL
    J Neurosci Nurs; 2008 Dec; 40(6):362-8. PubMed ID: 19170304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mannital induced acute renal failure].
    Du J; Cao J; Zhao H
    Zhonghua Wai Ke Za Zhi; 1996 Jul; 34(7):436-7. PubMed ID: 9590800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannitol and Outcome in Intracerebral Hemorrhage: Propensity Score and Multivariable Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Results.
    Wang X; Arima H; Yang J; Zhang S; Wu G; Woodward M; Muñoz-Venturelli P; Lavados PM; Stapf C; Robinson T; Heeley E; Delcourt C; Lindley RI; Parsons M; Chalmers J; Anderson CS;
    Stroke; 2015 Oct; 46(10):2762-7. PubMed ID: 26265125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and safety of glycerol versus mannitol in patients with cerebral oedema and elevated intracranial pressure: A systematic review and meta-analysis.
    Wang J; Ren Y; Wang SF; Kan LD; Zhou LJ; Fang HM; Fan H
    J Clin Pharm Ther; 2021 Apr; 46(2):504-514. PubMed ID: 33217016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study.
    Kerwin AJ; Schinco MA; Tepas JJ; Renfro WH; Vitarbo EA; Muehlberger M
    J Trauma; 2009 Aug; 67(2):277-82. PubMed ID: 19667879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of serum osmolality monitoring in patients with severe intracranial lesion].
    Ding Y; Duan A; Lu X
    Zhonghua Wai Ke Za Zhi; 1996 Apr; 34(4):224-8. PubMed ID: 9387687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of shock subsequent to treatment of intracranial hypertension by mannitol injection combined with hyperventilation.
    Inoue S; Ninaga H; Kawaguchi M; Furuya H
    J Neurosurg Anesthesiol; 1998 Apr; 10(2):113-5. PubMed ID: 9559770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in osmotic response to sustained mannitol administration.
    Keyrouz SG; Dhar R; Diringer MN
    Neurocrit Care; 2008; 9(2):204-9. PubMed ID: 18563637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formula for use of mannitol in patients with intracerebral haemorrhage and high intracranial pressure.
    Tan G; Zhou J; Yuan D; Sun S
    Clin Drug Investig; 2008; 28(2):81-7. PubMed ID: 18211116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure associated with mannitol infusion and reversal with ultrafiltration and hemodialysis.
    Sakemi T; Ikeda Y; Ohtsuka N; Ohtsuka Y; Tomiyoshi Y; Baba N
    Nephron; 1996; 73(4):733-4. PubMed ID: 8856292
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical treatment of intracerebral hemorrhage.
    Sacco S; Marini C; Carolei A
    Neurol Sci; 2004 Mar; 25 Suppl 1():S6-9. PubMed ID: 15045610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.